BusinessAI imageBeta Bionics Prices $150 Million Public Offering of Stock and Warrants
Beta Bionics, Inc. (Nasdaq: BBNX) announced the pricing of an underwritten public offering totaling $150 million. The offering includes 7,652,175 shares of common stock and pre-funded warrants. This financial move aims to support the company's growth and development initiatives in the biotechnology sector.
Legal Desire Media And Insights·




